Samit Hirawat
InvestorMedical Advisor at Abingworth
About
Samit Hirawat, M.D., joined Abingworth in June 2026 as Medical Advisor, bringing background in drug development. He previously served as Chief Medical Officer and Head of Global Drug Development at Bristol Myers Squibb, overseeing product development across therapeutic areas, and earlier held senior roles at Novartis (EVP and Head of Oncology Development), PTC Therapeutics, and Pfizer. He earned his MBBS at Sawai Man Singh Medical College in India and completed internal medicine residency and medical oncology training at North Shore University Hospital in New York.
Invests in
Biotech
Investments
Board seats
Cytospire TherapeuticsK-2 Therapeutics, LLCPacira Biosciences
Per the firm's website.
Colleagues at Abingworth
Alex Asquith
Counsel at Abingworth
Andrew Sinclair
Managing Director, Head of Publics & Late Stage at Abingworth
Ankur Shah
Vice President, CCD at Abingworth
Anna Slezak
Senior Associate at Abingworth
Bali Muralidhar
Global Head of Life Sciences & CIO at Abingworth
Carlos Paya
Venture Partner at Abingworth
Dayle Hogg
Operating Executive at Abingworth
Diya Malhotra
Principal at Abingworth